NURO

NeuroMetrix Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NURO price

NeuroMetrix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment NURO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NURO

Valuation

P/E

0.00

Sector 0.84

Industry -1.42

P/BV

0.00

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

6.89

Sector -43.66

Industry -35.45

EV/EBIT

6.68

Sector -47.57

Industry -38.86

P/EBITDA

Sector -31.25

Industry -21.12

P/EBIT

Sector -42.58

Industry -25.59

P/Total Assets

Sector 0.82

Industry 0.70

P/Net Current Assets

0.00

Sector -23.77

Industry -59.56

P/Working Capital

0.00

Sector -3.73

Industry -1.93

EPS

-3.91

Sector -0.70

Industry -1.22

BVPS

7.16

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

55.45%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-327.59%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.04

Sector 0.13

Industry 0.06

Profitability

ROE

-54.58%

Sector -24.30%

Industry -38.97%

ROA

-50.98%

Sector -24.50%

Industry -49.14%

ROIC

-553.80%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

14.84

Sector 1.92

Industry 2.55

Net Debt / EBITDA

6.89

Sector -23.10

Industry -8.80

Net Debt / EBIT

6.68

Sector -17.84

Industry -36.75

Net Debt / Equity

-0.92

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.54

Equity/Assets

0.93

Sector 0.46

Industry 0.52

Liabilities/Assets

0.07

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

-18.16%

Sector -

Industry -

5Y Earnings CAGR

27.91%

Sector -

Industry -

Fundamentals NURO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NURO NeuroMetrix Inc.	$0.00	-	0.00%	0.00	0.00	-54.58%	-100.00%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%
SYK Stryker Corp.	$298.82	-19.12%	1.18%	30.25	4.70	15.55%	14.43%
PHG Koninklijke Philips NV	$25.60	-6.71%	3.91%	19.13	1.87	9.80%	6.30%
INMD InMode Ltd.	$14.09	-7.97%	0.00%	10.83	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$190.65	3.33%	2.20%	55.79	2.15	3.85%	6.29%
DXCM DexCom Inc.	$85.63	28.57%	0.00%	33.25	12.68	38.14%	20.12%
EW Edwards Lifesciences Corp.	$86.82	16.32%	0.00%	49.74	4.66	9.37%	15.43%
ALGN Align Technology Inc.	$147.89	13.37%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$28.84	-17.84%	2.68%	21.68	4.71	21.74%	9.20%
IRMD iRadimed Corporation	$88.03	21.26%	1.43%	49.39	11.19	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$94.68	-5.87%	1.02%	22.50	1.44	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NURO - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT NeuroMetrix

NeuroMetrix Inc.

Average Investor10 user rating

4.0 (0 people)

United States

30 years

Founded: 1996

2004

Time since IPO - 22 years

20

Employees

NeuroMetrix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $14.31 million.

The company employs approximately 20 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, NeuroMetrix Inc. reported $3.03 million in revenue, generating net income of $-7.81 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NURO.

Market cap

Net worth

$14.31 million

$14,310,000.00

Assets

$15.32 million

$15,320,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

$5.44 Thousand

$5,441.26

Sector

Health

Industry

Medical Supplies and Equipment

NURO

NURO revenue and profits

Financial Results NURO

DRAG THE FRAME TO SEE MORE DATA

NURO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76